A prospective, single-center, randomized, double masked, sham controlled study to evaluate the safety, efficacy and tolerability of OTX-TI (sustained release travoprost) Intracameral Depot compared to topical travoprost in subjects with OA & OHT.
Research Grant
Administered By
Ophthalmology
Awarded By
Ocular Therapeutix Inc
Start Date
February 17, 2017
End Date
January 18, 2019
Administered By
Ophthalmology
Awarded By
Ocular Therapeutix Inc
Start Date
February 17, 2017
End Date
January 18, 2019